These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6415000)

  • 41. DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression.
    Tonnelle C; DeMars R; Long EO
    EMBO J; 1985 Nov; 4(11):2839-47. PubMed ID: 2998758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on human Ia supertypic specificities by complement fixation on PHA blasts. I. Serological properties of DC1 specificity.
    Guilherme L; Colombani M; Sansonetti N; Degos L; Colombani J
    Rev Fr Transfus Immunohematol; 1983 Sep; 26(4):379-94. PubMed ID: 6197740
    [No Abstract]   [Full Text] [Related]  

  • 43. Expression of T-lymphoblast-encoded HLA-DR, MT, and SB antigens on human T-B lymphoblast hybrids.
    Howell DN; Hartzman RJ; Cresswell P
    Hum Immunol; 1983 Oct; 8(2):167-75. PubMed ID: 6417070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human MHC class II molecules as differentiation markers.
    van Heyningen V; Guy K; Newman R; Steel CM
    Immunogenetics; 1982; 16(5):459-69. PubMed ID: 6984012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones.
    Jacobson S; Nepom GT; Richert JR; Biddison WE; McFarland HF
    J Exp Med; 1985 Jan; 161(1):263-8. PubMed ID: 2578544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing.
    Andrews DW; Bono MR; Strominger JL
    Biochemistry; 1982 Dec; 21(26):6625-8. PubMed ID: 6961940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex.
    Roux-Dosseto M; Auffray C; Lillie JW; Boss JM; Cohen D; DeMars R; Mawas C; Seidman JG; Strominger JL
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6036-40. PubMed ID: 6310612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple HLA-DR antigens: detection with monoclonal antibodies and translation in vitro.
    Finn OJ; Levy R
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2658-62. PubMed ID: 6979750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain.
    Auffray C; Korman AJ; Roux-Dosseto M; Bono R; Strominger JL
    Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6337-41. PubMed ID: 6815651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping, nucleotide sequence, and polymorphism of a new HLA class II light chain gene.
    Inoko H; Ando A; Trowsdale J; Tsuji K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):621-3. PubMed ID: 2495625
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.
    Accolla RS
    J Exp Med; 1984 Feb; 159(2):378-93. PubMed ID: 6420499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of novel human MHC class II mutant B-cell lines by integrating YAC DNA into a cell line homozygously deleted for the MHC class II region.
    Fabb SA; Davies AF; Correa I; Kelly AP; Mackie C; Trowsdale J; Ragoussis J
    Hum Mol Genet; 1997 Aug; 6(8):1295-304. PubMed ID: 9259276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
    Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
    Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subset analysis of human class II molecules controlled by the DR2/Dw2 haplotype: two separate DR subsets carry the DR2 specificity.
    Tanigaki N; Tosi R; Ferrara GB
    Immunogenetics; 1986; 24(2):95-102. PubMed ID: 2427443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
    Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
    J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.